ABL kinase is significantly implicated in cancer, particularly in chronic myeloid leukemia (CML). The most notorious link is the creation of the BCR-ABL fusion protein due to a chromosomal translocation commonly referred to as the Philadelphia chromosome. This abnormal fusion protein has constitutive tyrosine kinase activity, which leads to uncontrolled cell proliferation and survival, hallmark features of cancer.